Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. (GEDSF)
GEDSF Stock Price Chart
Explore Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. interactive price chart. Choose custom timeframes to analyze GEDSF price movements and trends.
GEDSF Company Profile
Discover essential business fundamentals and corporate details for Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. (GEDSF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Pharmaceuticals
IPO Date
3 Jan 2000
Employees
10.94K
Website
https://www.richter.huCEO
Gabor Orban
Description
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. researches, develops, manufactures, markets, and sells pharmaceutical products worldwide. The company operates through two segments, Pharmaceuticals, and Wholesale and Retail. It develops and manufactures products in various therapeutic areas, including women's healthcare, cardiovascular, and central nervous system. The company women's healthcare products include contraceptives, endometriosis, fertility, menopause, vaginal infections, and preparations used for the treatment of uterine fibroids. It also offers central nervous system products, such as products for the treatment of chronic cerebral circulatory disorders and neuropathic pain; and anaesthetics, anti-anxiety medications, sleeping pills, and anti-epileptic medicines, as well as products for the prevention and treatment of various cardiovascular diseases. In addition, the company produces various over-the-counter products for various health problems comprising Escapelle and Postinor, an emergency contraceptive pill; Panangin and Folik for pregnancy supplementation; Stopdiar and Nifuroxazide to treat diarrhea; RICHTER CycleBalance for infertility and PCOS; Groprinosin for antiviral and immunostimulant; Moilec for back and joint pain; Fasconal, a pain relief tablet; Magnezin, a magnesium supplementation; Aflamil, an anti-inflammatory and antirheumatic cream; Oralsept, a sore throat, anti-inflammatory, local anesthetic, and before and after oral surgery spray; Lordestin for allergy; and Curiosin for wound care. Further, it provides financial and accounting, social welfare, portfolio and project management, catering, carriage transportation, engineering, quality control, trading, asset management, and biotechnological services. Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. was founded in 1901 and is headquartered in Budapest, Hungary.
GEDSF Financial Timeline
Browse a chronological timeline of Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 May 2026
Upcoming earnings on 26 Feb 2026
Upcoming earnings on 6 Nov 2025
Earnings released on 6 Aug 2025
EPS came in at $283.75 , while revenue for the quarter reached $241.49B .
Dividend declared on 4 Jun 2025
A dividend of $1.46 per share was announced, adjusted to $1.46. The dividend was paid on 23 Jun 2025.
Earnings released on 13 May 2025
EPS came in at $373.00 , while revenue for the quarter reached $224.02B .
Earnings released on 28 Feb 2025
Earnings released on 12 Nov 2024
Earnings released on 6 Aug 2024
EPS came in at $382.92 , while revenue for the quarter reached $216.26B .
Dividend declared on 6 Jun 2024
A dividend of $1.17 per share was announced, adjusted to $1.17. The dividend was paid on 24 Jun 2024.
Earnings released on 25 Apr 2024
EPS came in at $373.00 , while revenue for the quarter reached $203.43B .
Earnings released on 29 Feb 2024
EPS came in at $294.00 , while revenue for the quarter reached $188.54B .
Earnings released on 31 Dec 2023
EPS came in at $197.00 , while revenue for the quarter reached $203.18B .
Earnings released on 30 Jun 2023
EPS came in at $155.26 , while revenue for the quarter reached $203.78B .
Dividend declared on 7 Jun 2023
A dividend of $1.14 per share was announced, adjusted to $1.14. The dividend was paid on 26 Jun 2023.
Earnings released on 31 Mar 2023
EPS came in at $210.00 , while revenue for the quarter reached $209.65B .
Earnings released on 31 Dec 2022
EPS came in at -$144.55 , while revenue for the quarter reached $223.97B .
Earnings released on 30 Sept 2022
EPS came in at $442.00 , while revenue for the quarter reached $217.81B .
Earnings released on 30 Jun 2022
EPS came in at $411.00 , while revenue for the quarter reached $192.92B .
Dividend declared on 8 Jun 2022
A dividend of $0.59 per share was announced, adjusted to $0.59. The dividend was paid on 27 Jun 2022.
Earnings released on 31 Mar 2022
EPS came in at $199.00 , while revenue for the quarter reached $168.06B .
Earnings released on 31 Dec 2021
EPS came in at $249.43 , while revenue for the quarter reached $176.27B .
Earnings released on 30 Sept 2021
EPS came in at $205.00 , while revenue for the quarter reached $157.52B .
Earnings released on 30 Jun 2021
EPS came in at $151.00 , while revenue for the quarter reached $155.91B .
Dividend declared on 4 Jun 2021
A dividend of $0.78 per share was announced, adjusted to $0.78. The dividend was paid on 24 Jun 2021.
Earnings released on 31 Mar 2021
EPS came in at $145.00 , while revenue for the quarter reached $140.89B .
Earnings released on 31 Dec 2020
EPS came in at $116.00 , while revenue for the quarter reached $150.39B .
Earnings released on 30 Sept 2020
EPS came in at $121.00 , while revenue for the quarter reached $137.70B .
GEDSF Stock Performance
Access detailed GEDSF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.